We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
183 hedge funds and large institutions have $1.18B invested in Amneal Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more capital invested
Capital invested by funds: $874M → $1.18B (+$306M)
26% more call options, than puts
Call options by funds: $609K | Put options by funds: $483K
14% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 57
1.19% more ownership
Funds ownership: 44.92% → 46.11% (+1.2%)
1% more funds holding
Funds holding: 181 → 183 (+2)
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
183
Holders Change
+2
Holders Change %
+1.1%
% of All Funds
2.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
65
Reduced
57
Closed
25
Calls
$609K
Puts
$483K
Net Calls
+$126K
Net Calls Change
-$1.08M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$12.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$9.93M |
| 3 |
BlackRock
New York
|
+$8.82M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8.75M |
| 5 |
JP Morgan Chase
New York
|
+$6.08M |
Top Sellers
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$22.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.57M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$6.71M |
| 4 |
Goldman Sachs
New York
|
-$4.12M |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$3.6M |
